Order Article Reprints

Su Y-L, Tsai K-L, Chiu T-J, Lin Y-M, Lee K-C, Lu C-C, Chen H-H, Wu C-C, Hsu H-C. Development and Validation of a Novel Serum Prognostic Marker for Patients with Metastatic Colorectal Cancer on Regorafenib Treatment. Cancers. 2021; 13(20):5080. https://doi.org/10.3390/cancers13205080

Su, Yu-Li, Kai-Lung Tsai, Tai-Jan Chiu, Yueh-Ming Lin, Ko-Chao Lee, Chien-Chang Lu, Hong-Hwa Chen, Chia-Che Wu, and Hung-Chih Hsu. 2021. "Development and Validation of a Novel Serum Prognostic Marker for Patients with Metastatic Colorectal Cancer on Regorafenib Treatment" Cancers 13, no. 20: 5080. https://doi.org/10.3390/cancers13205080

Su, Y.-L., Tsai, K.-L., Chiu, T.-J., Lin, Y.-M., Lee, K.-C., Lu, C.-C., Chen, H.-H., Wu, C.-C., & Hsu, H.-C. (2021). Development and Validation of a Novel Serum Prognostic Marker for Patients with Metastatic Colorectal Cancer on Regorafenib Treatment. Cancers, 13(20), 5080. https://doi.org/10.3390/cancers13205080